moffitt cancer center

Moffitt, Sanford-Burnham and Florida Hospital create Personalize...

http://www.eurekalert.org/rss/business.xml  Tue, 02/07/2012 - 23:00

(Sanford-Burnham Medical Research Institute) Moffitt Cancer Center, Sanford-Burnham Medical Research Institute and Florida Hospital have announced they will collaborate on the creation of a Personalized Medicine Partnership of Florida.

The partnership will conduct collaborative research to accelerate discovery and develop new treatments in the areas of cancer and metabolic diseases, including obesity, diabetes and cardiovascular disease.


 

Oracle, Moffitt Collaborate On Cancer Informatics System

InformationWeek Business Intelligence  Wed, 03/30/2011 - 10:04

Moffitt Cancer Center is using Oracle technology to build a scalable, secure data analysis platform to support personalized cancer care and research.


 

Moffitt Cancer Center signs licensing agreement with Proteacel, ...

http://www.eurekalert.org/rss/business.xml  Wed, 03/17/2010 - 22:00

(H. Lee Moffitt Cancer Center & Research Institute) Moffitt Cancer Center and Proteacel LLC announced today that they have entered a licensing agreement under which Proteacel has acquired the exclusive rights to the PORE technology for delivery of genes into cells.


 

New Center of Excellence targets reducing disparities in cancer ...

http://www.eurekalert.org/rss/business.xml  Sun, 06/14/2009 - 22:00

(University of South Florida Health) A new Center of Excellence at the University of South Florida and Moffitt Cancer Center will focus on research, education and training, and community outreach to reduce cancer health disparities among minority and underserved populations.

The joint program is funded by a $6 million grant from the National Institutes of Health.


 

Moffitt Cancer Center signs licensing agreement with Frantz BioM...

http://www.eurekalert.org/rss/business.xml  Tue, 05/19/2009 - 22:00

(H. Lee Moffitt Cancer Center & Research Institute) Moffitt Cancer Center and Frantz BioMarkers, LLC have signed a license agreement on phospholipid biomarkers of ovarian cancer.